EP2906252
Samtengd efnasambönd pyrrólóbensódíasepín-and-HER2-mótefnis
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.10.2013EP published:
14.6.2017EP application number:
13788691.7
EP translation filed:
28.8.2017Grant published:
15.9.2017EPO information:
European Patent Register
Max expiry date:
10.10.2033Expiry date:
10.10.2018
Title:
PYRROLOBENZODIAZEPINE-ANTI-HER2 ANTIBODY CONJUGATES
Timeline
Today
11.10.2013EP application
14.6.2017EP Publication
28.8.2017Translation submitted
15.9.2017Registration published
10.10.2018Expires
Owner
Name:
ADC Therapeutics SAAddress:
Route de la Corniche 3B, 1066, Epalinges, CH
Name:
Medimmune LimitedAddress:
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB
Inventor
Name:
VAN BERKEL, Patricius Hendrikus CornelisAddress:
Lausanne, CH
Name:
HOWARD, Philip WilsonAddress:
LondonGreater London E1 2AX, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261712924 PDate:
12.10.2012Country:
US
Number:
201261712928 PDate:
12.10.2012Country:
US
Number:
201361784270 PDate:
14.3.2013Country:
US
Number:
201361784233 PDate:
14.3.2013Country:
US
Number:
201361784249 PDate:
14.3.2013Country:
US
Classification
Categories:
A61K 47/68, A61P 35/00, C07K 16/32, A61K 39/395, A61K 31/551
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 2.10.2017
Expires: 10.10.2018
Payer: Árnason Faktor